Revenue (Quarterly) Chart

View Revenue (Quarterly) for PINK.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 0.6963M
March 31, 2026 0.5276M
December 31, 2025 0.9922M
September 30, 2025 0.7383M
June 30, 2025 0.7004M
March 31, 2025 0.7895M
December 31, 2024 0.4099M
September 30, 2024 0.2843M
June 30, 2024 0.337M
March 31, 2024 0.1326M
December 31, 2023 0.099M
September 30, 2023 0.1157M
June 30, 2023 0.1805M
March 31, 2023 0.1491M
December 31, 2022 0.0994M
September 30, 2022 0.0559M
June 30, 2022 0.0195M
March 31, 2022 0.00
December 31, 2021 0.0113M
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
Date Value
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Therma Bright, Inc. 0.0702M
Aurora Spine Corp. 6.085M
Ocumetics Technology Corp. 0.00
Bausch + Lomb Corp. 1.930B
HLS Therapeutics, Inc. 20.31M

Revenue (Quarterly) Related Metrics